TP53 and gastric cancer: A gradual decrease in the expression of apoptosis-related Bcl-2 protein was observed, suggesting that the anti-tumor effects of rAd-p53 and oxaliplatin were mediated by a mechanism that promoted apoptosis in gastric cancer cells.73